Feed excerpt — reported by STAT News
New cases show AAV gene therapies like Zolgensma carry tumor risks, raising key concerns for SMA patients and forcing doctors to rethink treatment options.
MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →